{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:47:54Z","timestamp":1787168874692,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00270-020-02674-4","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T16:02:44Z","timestamp":1603123364000},"page":"281-288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Comparison of Safety and Efficacy of Percutaneous Microwave Ablation of Central Versus Peripheral Renal Cell Carcinoma"],"prefix":"10.1007","volume":"44","author":[{"given":"Thomas J.","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9232-4069","authenticated-orcid":false,"given":"Ronald S.","family":"Arellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"key":"2674_CR1","doi-asserted-by":"publisher","first-page":"735","DOI":"10.2214\/AJR.15.14752","volume":"205","author":"LJ Higgins","year":"2015","unstructured":"Higgins LJ, Hong K. Renal ablation techniques: state of the Art. Am J Roentgenol. 2015;205:735\u201341.","journal-title":"Am J Roentgenol"},{"key":"2674_CR2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2214\/ajr.185.1.01850072","volume":"185","author":"DA Gervais","year":"2005","unstructured":"Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 2, lessons learned with ablation of 100 tumors. Am J Roentgenol. 2005;185:72\u201380.","journal-title":"Am J Roentgenol"},{"key":"2674_CR3","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2214\/AJR.12.8618","volume":"200","author":"TD Atwell","year":"2013","unstructured":"Atwell TD, Schmit GD, Boorjian SA, et al. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation. Am J Roentgenol. 2013;200:461\u20136.","journal-title":"Am J Roentgenol"},{"key":"2674_CR4","first-page":"1156","volume":"61","author":"EO Olweny","year":"2012","unstructured":"Olweny EO, Park SK, Tan YK, Best SL, Trimmer C, Cadeddu JA. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical t1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 y of follow-up. EurUrol. 2012;61:1156\u201361.","journal-title":"EurUrol"},{"key":"2674_CR5","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","volume":"41","author":"F Faul","year":"2009","unstructured":"Faul F, Erdfelder E, Buchner A, Lang A-G. Statistical power analyses using g*power 3.1: tests for correlation and regression analyses. Behav Res Method. 2009;41:1149\u201360.","journal-title":"Behav Res Method"},{"issue":"(suppl_1)","key":"2674_CR6","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1148\/rg.25si055501","volume":"25","author":"CJ Simon","year":"2005","unstructured":"Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. RadioGraphics. 2005;25((suppl_1)):S69\u2013S83.","journal-title":"RadioGraphics"},{"key":"2674_CR7","first-page":"48","volume":"23","author":"TD Atwell","year":"2012","unstructured":"Atwell TD, Carter RE, Schmit GD, et al. Complications following 573 percutaneous renal radiofrequency and cryoablation procedures. J VascIntervRadiol. 2012;23:48\u2013544.","journal-title":"J VascIntervRadiol"},{"key":"2674_CR8","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1089\/end.2008.0499","volume":"23","author":"A Gupta","year":"2009","unstructured":"Gupta A, Raman JD, Leveillee RJ, et al. General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results. J Endourol. 2009;23:1099\u2013105.","journal-title":"J Endourol"},{"key":"2674_CR9","first-page":"1643","volume":"28","author":"Y Dai","year":"2017","unstructured":"Dai Y, Covarrubias D, Uppot R, Arellano RS. Image-guided percutaneous radiofrequency ablation of central renal cell carcinoma: assessment of clinical efficacy and safety in 31 tumors. J VascIntervRadiol. 2017;28:1643\u201350.","journal-title":"J VascIntervRadiol"},{"key":"2674_CR10","first-page":"1249","volume":"31","author":"JT Marion","year":"2020","unstructured":"Marion JT, Schmitz JJ, Schmit GD, et al. Safety and efficacy of retrograde pyeloperfusion for ureteral protection during renal tumorcryoablation. J VascIntervRadiol. 2020;31:1249\u201355.","journal-title":"J VascIntervRadiol"},{"key":"2674_CR11","first-page":"1551","volume":"16","author":"TM Wah","year":"2005","unstructured":"Wah TM, Koenig P, Irving HC, Gervais DA, Mueller PR. Radiofrequency ablation of a central renal tumor: protection of the collecting system with a retrograde cold dextrose pyeloperfusion technique. J VascIntervRadiol. 2005;16:1551\u20135.","journal-title":"J VascIntervRadiol"},{"key":"2674_CR12","first-page":"1034","volume":"19","author":"CP Cantwell","year":"2008","unstructured":"Cantwell CP, Wah TM, Gervais DA, et al. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water. J VascIntervRadiol. 2008;19:1034\u201340.","journal-title":"J VascIntervRadiol"},{"key":"2674_CR13","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/j.ejrad.2016.09.018","volume":"85","author":"Y Gao","year":"2016","unstructured":"Gao Y, Liang P, Yu X, et al. Microwave treatment of renal cell carcinoma adjacent to renal sinus. Eur J Radiol. 2016;85:2083\u20139.","journal-title":"Eur J Radiol"},{"key":"2674_CR14","first-page":"1203","volume":"41","author":"SA Wells","year":"2016","unstructured":"Wells SA, Wheeler KM, Mithqal A, Patel MS, Brace CL, Schenkman NS. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment. AbdomRadiol (NY). 2016;41:1203\u201311.","journal-title":"AbdomRadiol (NY)"},{"key":"2674_CR15","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.2214\/AJR.18.19775","volume":"211","author":"SM Thompson","year":"2018","unstructured":"Thompson SM, Schmitz JJ, Thompson RH, et al. Introduction of microwave ablation into a renal ablation practice: valuable lessons learned. AJR Am J Roentgenol. 2018;211:1381\u20139.","journal-title":"AJR Am J Roentgenol"},{"key":"2674_CR16","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3109\/02656736.2016.1172118","volume":"32","author":"CN Chen","year":"2016","unstructured":"Chen CN, Liang P, Yu J, et al. Contrast-enhanced ultrasound-guided percutaneous microwave ablation of renal cell carcinoma that is inconspicuous on conventional ultrasound. Int J Hyperth. 2016;32:607\u201313.","journal-title":"Int J Hyperth"},{"key":"2674_CR17","first-page":"1025","volume":"43","author":"BM Aarts","year":"2020","unstructured":"Aarts BM, Prevoo W, Meier MAJ, et al. Percutaneous microwave ablation of histologically proven t1 renal cell carcinoma. CardiovascIntervRadiol. 2020;43:1025\u201333.","journal-title":"CardiovascIntervRadiol"},{"key":"2674_CR18","doi-asserted-by":"publisher","first-page":"e447","DOI":"10.5114\/pjr.2019.89966","volume":"84","author":"K Kamadi","year":"2019","unstructured":"Kamadi K, Arellano R. Comparison of clinical outcome between pyeloperfused versus non-pyeloperfused microwave ablation of renal cell carcinoma. Pol J Radiol. 2019;84:e447\u2013e45252.","journal-title":"Pol J Radiol"},{"key":"2674_CR19","first-page":"1685","volume":"29","author":"W Zhou","year":"2018","unstructured":"Zhou W, Herwald SE, Uppot RN, Arellano RS. Risk assessment of chronic kidney disease following microwave ablation for stage t1 renal cell carcinoma. J VascIntervRadiol. 2018;29:1685\u201391.","journal-title":"J VascIntervRadiol"},{"key":"2674_CR20","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.juro.2009.05.035","volume":"182","author":"A Kutikov","year":"2009","unstructured":"Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size. Locat Depth. J Urol. 2009;182:844\u201353.","journal-title":"Locat Depth. J Urol"},{"key":"2674_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1148\/radiol.14132958","volume":"273","author":"M Ahmed","year":"2014","unstructured":"Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria\u2014a 10-year update. Radiology. 2014;273:241\u201360.","journal-title":"Radiology"},{"key":"2674_CR22","first-page":"1432","volume":"28","author":"O Khalilzadeh","year":"2017","unstructured":"Khalilzadeh O, Baerlocher MO, Shyn PB, et al. Proposal of a new adverse event classification by the society of interventional radiology standards of practice committee. J VascIntervRadiol. 2017;28:1432\u20137.","journal-title":"J VascIntervRadiol"},{"key":"2674_CR23","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.juro.2017.04.100","volume":"198","author":"S Campbell","year":"2017","unstructured":"Campbell S, Uzzo RG, Allaf ME, et al. Renal mass and localized renal cancer: aua guideline. J Urol. 2017;198:520\u20139.","journal-title":"J Urol"},{"key":"2674_CR24","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/bju.12349","volume":"113","author":"TM Wah","year":"2015","unstructured":"Wah TM, Irving HC, Gregory W, Cartledge J, Joyce AD, Selby PJ. Radiofrequency ablation (rfa) of renal cell carcinoma (rcc): experience in 200 tumours. BJU Int. 2015;113:416\u201328.","journal-title":"BJU Int"},{"key":"2674_CR25","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1080\/02656736.2019.1675913","volume":"36","author":"R Grange","year":"2019","unstructured":"Grange R, Tradi F, Izaaryene J, Daidj N, et al. Computed tomography-guided percutaneous cryoablation of T1b renal tumors: safety, functional and oncological outcomes. Int J Hyperth. 2019;36:1065\u201371.","journal-title":"Int J Hyperth"},{"key":"2674_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.urology.2019.08.005","volume":"133","author":"CA Murray","year":"2019","unstructured":"Murray CA, Welch BT, Schmit GD, et al. Safety and efficacy of percutaneous image-guided cryoablation of completely endophytic renal masses. Urology. 2019;133:151\u20136.","journal-title":"Urology"},{"key":"2674_CR27","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2214\/ajr.185.1.01850064","volume":"185","author":"DA Gervais","year":"2005","unstructured":"Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 1, indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. Am J Roentgenol. 2005;185:64\u201371.","journal-title":"Am J Roentgenol"},{"key":"2674_CR28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1080\/02656736.2018.1475684","volume":"35","author":"G Hao","year":"2018","unstructured":"Hao G, Hao Y, Cheng Z, et al. Local tumor progression after ultrasound-guided percutaneous microwave ablation of stage T1a renal cell carcinoma: risk factors analysis of 171 tumors. Int J Hyperth. 2018;35:62\u201370.","journal-title":"Int J Hyperth"},{"key":"2674_CR29","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1148\/radiol.14132548","volume":"272","author":"GD Schmit","year":"2014","unstructured":"Schmit GD, Schenck LA, Thompson RH, et al. Predicting renal cryoablation complications: new risk score based on tumor size and location and patient history. Radiology. 2014;272:903\u201310.","journal-title":"Radiology"},{"key":"2674_CR30","first-page":"80","volume":"27","author":"JX Chen","year":"2016","unstructured":"Chen JX, Guzzo TJ, Malkowicz SB, et al. Complication and readmission rates following same-day discharge after percutaneous renal tumor ablation. J VascIntervRadiol. 2016;27:80\u20136.","journal-title":"J VascIntervRadiol"},{"key":"2674_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/bju.15224","author":"JB John","year":"2020","unstructured":"John JB, Anderson M, Dutton T, et al. Percutaneous microwave ablation of renal masses in a UK cohort. BJU Int. 2020. https:\/\/doi.org\/10.1111\/bju.15224.","journal-title":"BJU Int"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-020-02674-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-020-02674-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-020-02674-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T01:40:01Z","timestamp":1634607601000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-020-02674-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["2674"],"URL":"https:\/\/doi.org\/10.1007\/s00270-020-02674-4","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,19]]},"assertion":[{"value":"26 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this type of study, consent for publication is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"This study has obtained IRB approval from Partners Healthcare, and the need for informed consent was waived.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}